Michigan’s Collaborative for Type 2 Diabetes (MCT2D), a statewide population health collaborative quality initiative, analyzed nearly 1,000 physician-submitted patient case summaries and needs assessments, finding that physicians needed help managing the burden of prior authorization.This […]
The Enhanced Primary Care Diabetes (EPCD) model is a nurse-led care delivery model that leverages multidisciplinary support to improve diabetes care quality in primary care settings. A study titled “Diabetes care delivery and outcomes by […]
There’s something oddly luxurious about sleeping in. The sun filters through the curtains, the alarm clock is blissfully silent, and your body stays at rest. Yet sleeping in is often treated as an indulgence, sometimes […]
In a first-of-its-kind study, researchers used a unique dataset to show that patients with type 2 diabetes have significantly worse financial outcomes than other patients.This article was originally published on MedicalXpress.com
Until now, the sensory neurons inside the tooth were primarily thought to send pain signals to the brain, but a new study shows those neurons are multitaskers that also trigger a jaw-opening reflex that almost […]
Chronic kidney disease (CKD) appears to be associated with a higher risk of tooth loss, with a higher prevalence of CKD seen among individuals with fewer than 20 teeth, according to a study published online […]
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor (DPP4i) use, according to a study published online […]
We’re constantly being reminded by news articles and social media posts that we should be getting more sleep. You probably don’t need to hear it again—not sleeping enough is bad for your brain, heart and […]
The blood pressure-lowering effect of nitrate-rich beetroot juice in older people may be due to specific changes in their oral microbiome, according to the largest study of its kind.This article was originally published on MedicalXpress.com
GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, […]
© 2025 SimplyWell.ca